VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $3.27 million. The enterprise value is $3.22 million.
Important Dates
The next estimated earnings date is Friday, June 13, 2025, after market close.
| Earnings Date | Jun 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 1.78 million shares outstanding. The number of shares has increased by 72.30% in one year.
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +72.30% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 4.14% |
| Float | 1.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.99 |
| Forward PS | 16.85 |
| PB Ratio | 7.18 |
| P/TBV Ratio | 9.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 26.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of 2.91.
| Current Ratio | 0.72 |
| Quick Ratio | 0.40 |
| Debt / Equity | 2.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,511.60 |
Financial Efficiency
Return on equity (ROE) is -378.40% and return on invested capital (ROIC) is -172.37%.
| Return on Equity (ROE) | -378.40% |
| Return on Assets (ROA) | -123.36% |
| Return on Invested Capital (ROIC) | -172.37% |
| Return on Capital Employed (ROCE) | -1,384.56% |
| Revenue Per Employee | $6,100 |
| Profits Per Employee | -$619,250 |
| Employee Count | 20 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.51% in the last 52 weeks. The beta is 1.04, so VivoSim Labs's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -84.51% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 43.17 |
| Average Volume (20 Days) | 73,545 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $122,000 and -$12.39 million in losses. Loss per share was -$9.78.
| Revenue | 122,000 |
| Gross Profit | -5.11M |
| Operating Income | -12.56M |
| Pretax Income | n/a |
| Net Income | -12.39M |
| EBITDA | -12.28M |
| EBIT | -12.56M |
| Loss Per Share | -$9.78 |
Full Income StatementBalance Sheet
The company has $1.16 million in cash and $1.06 million in debt, giving a net cash position of $101,000 or $0.06 per share.
| Cash & Cash Equivalents | 1.16M |
| Total Debt | 1.06M |
| Net Cash | 101,000 |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 364,000 |
| Book Value Per Share | 0.25 |
| Working Capital | -837,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.10 million and capital expenditures -$13,000, giving a free cash flow of -$10.11 million.
| Operating Cash Flow | -10.10M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -10.11M |
| FCF Per Share | -$5.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -10,293.44% |
| Pretax Margin | -10,150.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.30% |
| Shareholder Yield | -72.30% |
| Earnings Yield | -373.38% |
| FCF Yield | -304.79% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
VivoSim Labs has an Altman Z-Score of -136.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -136.51 |
| Piotroski F-Score | 2 |